Brian Burford

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

Ola Blixt, Deanna Bueti, Brian Burford et al. · Breast Cancer Research · 2011 · 205 citations · Full text

Life Sciences, Immunology, Oncology +17

Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers

Sylvain Julien, Aleksandar Ívetic, Anita Grigoriadis et al. · Cancer Research · 2011 · 195 citations

Medicine, Molecular Biology, Oncology +14

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control

Emanuele de Rinaldis, Patrycja Gazińska, Anca Mera et al. · BMC Genomics · 2013 · 87 citations · Full text

Medicine, Cancer Biology, Oncology +17

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility

Tai Kiuchi, Elena Ortíz-Zapater, James Monypenny et al. · Science Signaling · 2014 · 63 citations

Life Sciences, Cell Biology, Oncology +15

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

Brian Burford, A. Gentry-Maharaj, Rosalind Graham et al. · British Journal of Cancer · 2013 · 55 citations · Full text

Medicine, Immunology, Oncology +17